Notably, our recent study identified that the densities of CD8+ T cells within MC38 CRC tumors after its challenge implantation are two-fold greater in the tumors grown in mice immunized with nonreplicable MC38 CRC cells plus rGRA6Nt adjuvant than those grown in unimmunized mice. This evidence concerns the gene CD8A and colorectal carcinoma.